Atherothrombosis and the Management of the Vulnerable Vascular Patient-Reference-Cited by-同舟云学术

Atherothrombosis and the Management of the Vulnerable Vascular Patient

Published:2009-01 Issue:1 Volume:16 Page:24-34
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Arora Rohit,Rai Fasi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference27 articles.

1. Atherothrombosis: epidemiology, pathophysiology, and prevention.;Munger;J Am Pharm Assoc,2004

2. Pathophysiology of coronary artery disease.;Libby;Circulation,2005

3. Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic/magnetic resonance imaging.;Fuster;J Am Coll Cardiol,2005

4. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events.;Bhatt;J Invasive Cardiol,2003

5. Multiple complex coronary plaques in patients with acute myocardial infarction.;Goldstein;N Engl J Med,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Snake Venom’s Disintegrins and C-Type Lectins to Anti-Platelet Drugs;Toxins;2019-05-27

2. Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease;BMC Medical Genomics;2016-07-20

3. Clinical Risk Factors and Plaque Characteristics Associated with New Development of Contralateral Stenosis in Patients Undergoing Carotid Endarterectomy;Cerebrovascular Diseases;2016

4. A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel;Platelets;2011-09-15

5. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCγ2;Platelets;2010-01